Elanco Animal Health ELAN
NYSE ELAN
$23.53 -0.97 (-3.94%)
At close: Aug 20, 2026 · 1:57 PM UTC

Elanco Animal Health (ELAN) Construction in Progress (2024)

Elanco Animal Health (ELAN) posted Construction in Progress of $42.0 million for Q4 2024.

Elanco Animal Health (ELAN) Construction in Progress (2024) Analysis & Trends

Elanco Animal Health has reported Construction in Progress for 1 years, with the latest figure at $42.0 million in Q4 2024.

  • Quarterly Construction in Progress changed N/A year-over-year to $42.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $42.0 million (changed N/A YoY) and the FY2024 annual result came in at $42.0 million, changed N/A from the prior year.
  • Construction in Progress steadied at $42.0 million in Q4 2024 per ELAN's latest filing.
  • Over five years, Construction in Progress peaked at $42.0 million in Q4 2024 and troughed at $42.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn -
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn -
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 42.00 Mn